Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,457 | 1,344 | 99.7% |
| Education | $62.96 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,679 | 296 | $0 (2024) |
| Amgen Inc. | $2,575 | 177 | $0 (2024) |
| UCB, Inc. | $1,608 | 159 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,437 | 108 | $0 (2024) |
| Janssen Biotech, Inc. | $1,119 | 86 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,054 | 76 | $0 (2024) |
| Genentech USA, Inc. | $1,002 | 78 | $0 (2023) |
| PFIZER INC. | $806.31 | 78 | $0 (2024) |
| Celgene Corporation | $604.91 | 29 | $0 (2019) |
| GlaxoSmithKline, LLC. | $572.68 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,375 | 146 | ABBVIE INC. ($712.57) |
| 2023 | $2,747 | 175 | AbbVie Inc. ($924.80) |
| 2022 | $2,694 | 169 | ABBVIE INC. ($676.06) |
| 2021 | $2,584 | 175 | AbbVie Inc. ($694.94) |
| 2020 | $1,680 | 120 | AbbVie Inc. ($473.01) |
| 2019 | $2,427 | 164 | AbbVie, Inc. ($451.83) |
| 2018 | $2,705 | 211 | Genentech USA, Inc. ($309.80) |
| 2017 | $2,308 | 189 | AbbVie, Inc. ($446.15) |
All Payment Transactions
1,349 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $18.75 | General |
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Bone Health | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Immunology | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $11.83 | General |
| 10/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,995 | 38,595 | $1.4M | $764,740 |
| 2022 | 44 | 4,287 | 41,744 | $1.6M | $804,595 |
| 2021 | 44 | 4,394 | 42,388 | $1.6M | $851,058 |
| 2020 | 47 | 4,843 | 56,029 | $2.2M | $1.2M |
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 140 | 13,140 | $367,920 | $240,294 | 65.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 6,875 | $433,125 | $231,251 | 53.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 15 | 11,130 | $146,916 | $88,561 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 496 | 1,035 | $149,040 | $86,337 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 387 | $37,152 | $21,442 | 57.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 620 | $46,500 | $16,161 | 34.8% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 88 | 707 | $26,866 | $12,119 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 99 | $18,810 | $11,754 | 62.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 238 | 310 | $51,615 | $8,913 | 17.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 423 | 791 | $15,820 | $5,968 | 37.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 320 | 571 | $22,840 | $5,892 | 25.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 50 | 116 | $11,832 | $5,269 | 44.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 129 | 129 | $32,250 | $4,379 | 13.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 23 | 40 | $9,000 | $3,600 | 40.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 154 | 345 | $10,005 | $3,567 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 310 | 522 | $3,132 | $3,059 | 97.7% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 292 | 497 | $7,455 | $2,058 | 27.6% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2023 | 55 | 55 | $3,905 | $1,536 | 39.3% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 33 | 66 | $4,752 | $1,499 | 31.5% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 88 | 91 | $2,730 | $1,197 | 43.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 51 | $2,601 | $1,031 | 39.6% |
| 86039 | Measurement of antibody for assessment of autoimmune disorder, titer | Office | 2023 | 88 | 91 | $2,184 | $971.93 | 44.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 83 | 112 | $3,808 | $928.48 | 24.4% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 44 | 44 | $2,772 | $923.73 | 33.3% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 18 | 36 | $3,060 | $848.30 | 27.7% |
About Dr. Deepak Sree, MD
Dr. Deepak Sree, MD is a Rheumatology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1235391988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Sree, MD has received a total of $19,520 in payments from pharmaceutical and medical device companies, with $2,375 received in 2024. These payments were reported across 1,349 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($19,457).
As a Medicare-enrolled provider, Sree has provided services to 17,519 Medicare beneficiaries, totaling 178,756 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Huntsville, AL
- Active Since 06/25/2008
- Last Updated 01/09/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1235391988
Products in Payments
- RINVOQ (Biological) $2,306
- Cimzia (Drug) $1,532
- Enbrel (Biological) $1,353
- ORENCIA (Biological) $1,035
- COSENTYX (Biological) $1,027
- Humira (Biological) $908.31
- XELJANZ (Drug) $684.52
- ACTHAR (Biological) $606.76
- SKYRIZI (Biological) $596.77
- Rituxan (Biological) $591.82
- BENLYSTA (Biological) $572.68
- Tymlos (Biological) $517.30
- EVENITY (Biological) $506.89
- TREMFYA (Drug) $495.13
- Otezla (Drug) $409.09
- Actemra (Biological) $395.80
- COSENTYX (Drug) $382.91
- RINVOQ (Drug) $382.05
- SIMPONI ARIA (Biological) $377.78
- KEVZARA SARILUMAB INJECTION (Biological) $313.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Huntsville
Dr. William Shergy, Md, MD
Rheumatology — Payments: $257,107
Dr. Anil Warrier, M.d, M.D
Rheumatology — Payments: $12,511
Dr. Ayesha Jaleel, M.d, M.D
Rheumatology — Payments: $11,554
Robert Phillips, Md, MD
Rheumatology — Payments: $10,639
Dr. Margaret Meehan, Md, MD
Rheumatology — Payments: $10,146
Dr. Roxanna Sabghi, M.d, M.D
Rheumatology — Payments: $8,286